News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alvine Pharmaceuticals, Inc. Presents Celiac Disease Symptom Frequency and Severity Study Results at the 2012 American College of Gastroenterology Meeting


10/24/2012 9:18:31 AM

SAN CARLOS, Calif.--(BUSINESS WIRE)--Alvine Pharmaceuticals, Inc., a leader in celiac disease therapeutics development, today announced the presentation of patient-reported outcomes data at the 2012 American College of Gastroenterology meeting in Las Vegas, NV. The poster presentation included data on the frequency and severity of symptoms experienced by celiac disease patients attempting to adhere to a gluten-free diet. In the study, a disease-specific patient-reported outcome diary was used to collect daily symptom data from celiac disease patients.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES